ResearcherUniversity of PaviaNo recent work listed
Lorenzo Cobianchi
Matched on ORCID iD 0000-0002-6773-5453; OpenAlex author ID A5083807422. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 2 papers
Papers 7
- Co-design, co-learning, and co-production of an app for pancreatic cancer patients-the "Pancreas Plus" study protocol. Co-author DOI 10.21037/mhealth-22-48↗
- Editorial: New frontiers in pancreatic cancer care: Multidisciplinary approaches, the role of Pancreas Units, and their organizational impacts. Co-author DOI 10.3389/fsurg.2023.1182206↗
- Intraperitoneal chemotherapy in the management of pancreatic adenocarcinoma: A systematic review and meta-analysis. Last author DOI 10.1016/j.ejso.2022.05.030↗
- New Perspectives for Pancreatic Cancer Treatment. Will We Be Able to Ensure Equity to Care? Co-author DOI 10.1177/15533506211062398↗
- Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? Co-author DOI 10.1016/j.pan.2020.05.007↗
- Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. Last author DOI 10.2147/ott.s220971↗
- Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, mul… First author DOI 10.1186/s12885-019-6108-0↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Francesca Dal Mas · 3 shared papers, 2022–2023 · strength 0.80
- Paper New Perspectives for Pancreatic Cancer Treatment. Will We Be Able to Ensure Equity to Care? DOI 10.1177/15533506211062398↗
- Paper Co-design, co-learning, and co-production of an app for pancreatic cancer patients-the "Pancreas Plus" study protocol. DOI 10.21037/mhealth-22-48↗
- Paper Editorial: New frontiers in pancreatic cancer care: Multidisciplinary approaches, the role of Pancreas Units, and their… DOI 10.3389/fsurg.2023.1182206↗
- Viviana Vitolo · 3 shared papers, 2019–2020 · strength 0.33
- Paper Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. DOI 10.2147/ott.s220971↗
- Paper Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? DOI 10.1016/j.pan.2020.05.007↗
- Paper Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic aden… DOI 10.1186/s12885-019-6108-0↗
- Amelia Barcellini · 3 shared papers, 2019–2020 · strength 0.33
- Paper Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress. DOI 10.2147/ott.s220971↗
- Paper Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? DOI 10.1016/j.pan.2020.05.007↗
- Paper Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic aden… DOI 10.1186/s12885-019-6108-0↗
- Erica Pizzocaro · 1 shared paper, 2023 · strength 0.24
- Marzia Tripepi · 1 shared paper, 2023 · strength 0.24
- Giovanni Butturini · 1 shared paper, 2023 · strength 0.24
- Alessandro Venturi · 1 shared paper, 2023 · strength 0.24
- Francesca Valvo · 2 shared papers, 2019–2020 · strength 0.18
- Stefano Granieri · 1 shared paper, 2022 · strength 0.16
- Simone Frassini · 1 shared paper, 2022 · strength 0.16
- Ester M. Orlandi · 1 shared paper, 2020 · strength 0.10
- Angelica Facoetti · 1 shared paper, 2019 · strength 0.08
- Silvia Molinelli · 1 shared paper, 2019 · strength 0.08
- Roberto Orecchia · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.